Self-reported oral health and quality of life of postmenopausal breast cancer survivors on aromatase inhibitors and women without cancer diagnoses: a longitudinal analysis

Introduction Aromatase inhibitors (AIs) are a well-established component of adjuvant therapy in postmenopausal women with hormone receptor (HR) + early stage breast cancer (BCa). We explored in an 18-month cohort study whether subjective oral health (OH), subjective periodontal health (PH), and oral...

Full description

Saved in:
Bibliographic Details
Published in:Supportive care in cancer 2016-11, Vol.24 (11), p.4815-4824
Main Authors: Taichman, L. Susan, Van Poznak, Catherine H., Inglehart, Marita R.
Format: Article
Language:English
Subjects:
Aromatase Inhibitors - pharmacology
Aromatase Inhibitors - therapeutic use
Breast cancer
Breast Neoplasms - drug therapy
Breast Neoplasms - pathology
Cohort Studies
Dental health
Female
Humans
Medicine
Medicine & Public Health
Middle Aged
Nursing
Nursing Research
Oncology
Oral diseases
Oral Health - standards
Oral hygiene
Original Article
Pain Medicine
Postmenopause
Quality of life
Quality of Life - psychology
Rehabilitation Medicine
Self Report
Survivors
Tumors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Introduction Aromatase inhibitors (AIs) are a well-established component of adjuvant therapy in postmenopausal women with hormone receptor (HR) + early stage breast cancer (BCa). We explored in an 18-month cohort study whether subjective oral health (OH), subjective periodontal health (PH), and oral health-related quality of life (OHRQoL) of postmenopausal BCa survivors on AIs differ from those of women without cancer diagnoses, and whether saliva flow, OH, PH, and OHRQoL are related. Methods Data were collected from 29 postmenopausal BCa survivors on AIs and 29 postmenopausal women without cancer diagnoses. Socio-demographic information, OH, PH, and OHRQoL were collected at baseline and 6, 12, and 18 months later. Unstimulated whole saliva volume per 15 min was determined by drooling. Results The two groups did not differ in background characteristics at baseline. Women on AIs had poorer OH ( p  = .043), PH ( p  = .04), and OHRQoL ( p  = .017), and lower saliva flow rate ( p  
ISSN:0941-4355
1433-7339
DOI:10.1007/s00520-016-3336-6